Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeshi Nakanishi

Showing results (1-10 of 202) with videos related to

Pageof 21
Sort By:
Blood Purification|April 4, 2019
PrefaceTakeshi Nakanishi, Takahiro Kuragano
Clinical Kidney Journal|February 10, 2021
Potential hazards of recent trends in liberal iron use for renal anemiaTakeshi Nakanishi, Takahiro Kuragano
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 7, 2006
[Diabetic skin disorders]Takeshi Nakanishi, Masamitsu Ishii
Nihon Jinzo Gakkai Shi|November 26, 2009
[Renal anemia treatment and outcome of patients with chronic kidney disease]Takahiro Kuragano, Takeshi Nakanishi
Clinical Kidney Journal|March 22, 2024
Growing concerns about using hypoxia-inducible factor prolyl hydroxylase inhibitors for the treatment of renal anemiaTakeshi Nakanishi, Takahiro Kuragano
Contributions to Nephrology|July 25, 2018
Importance of Physiological Erythropoiesis in the Treatment of Chronic Kidney Disease-Associated AnemiaTakahiro Kuragano, Takeshi Nakanishi
The New England Journal of Medicine|June 13, 2019
Intravenous Iron and Maintenance HemodialysisTakeshi Nakanishi, Takahiro Kuragano
Journal of Biochemistry|May 23, 2003
Cloning and expression of the superoxide dismutase gene from the obligate anaerobic bacterium Desulfovibrio vulgaris (Miyazaki F)Takeshi Nakanishi, Hideo Inoue, Masaya Kitamura
European Journal of Dermatology : EJD|August 18, 2023
Cutaneous pseudolymphoma successfully treated with dupilumabShuji Sugiura, Takeshi Nakanishi, Noriki Fujimoto
Blood Purification|July 8, 2026
Clinical Changes After Tenapanor Initiation in Maintenance Hemodialysis Patients: A Two-Center Retrospective Observational StudySyu Iwasawa, Takeshi Nakanishi, Takahiro Kuragano
Pageof 21

Showing results (1-10 of 202) with videos related to

Sort By:
Pageof 21
Blood Purification|April 4, 2019
PrefaceTakeshi Nakanishi, Takahiro Kuragano
Clinical Kidney Journal|February 10, 2021
Potential hazards of recent trends in liberal iron use for renal anemiaTakeshi Nakanishi, Takahiro Kuragano
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 7, 2006
[Diabetic skin disorders]Takeshi Nakanishi, Masamitsu Ishii
Nihon Jinzo Gakkai Shi|November 26, 2009
[Renal anemia treatment and outcome of patients with chronic kidney disease]Takahiro Kuragano, Takeshi Nakanishi
Clinical Kidney Journal|March 22, 2024
Growing concerns about using hypoxia-inducible factor prolyl hydroxylase inhibitors for the treatment of renal anemiaTakeshi Nakanishi, Takahiro Kuragano
Contributions to Nephrology|July 25, 2018
Importance of Physiological Erythropoiesis in the Treatment of Chronic Kidney Disease-Associated AnemiaTakahiro Kuragano, Takeshi Nakanishi
The New England Journal of Medicine|June 13, 2019
Intravenous Iron and Maintenance HemodialysisTakeshi Nakanishi, Takahiro Kuragano
Journal of Biochemistry|May 23, 2003
Cloning and expression of the superoxide dismutase gene from the obligate anaerobic bacterium Desulfovibrio vulgaris (Miyazaki F)Takeshi Nakanishi, Hideo Inoue, Masaya Kitamura
European Journal of Dermatology : EJD|August 18, 2023
Cutaneous pseudolymphoma successfully treated with dupilumabShuji Sugiura, Takeshi Nakanishi, Noriki Fujimoto
Blood Purification|July 8, 2026
Clinical Changes After Tenapanor Initiation in Maintenance Hemodialysis Patients: A Two-Center Retrospective Observational StudySyu Iwasawa, Takeshi Nakanishi, Takahiro Kuragano
Pageof 21